Emcure Pharmaceuticals Ltd. Block Trade on NSE14 hours ago
A block trade of approximately 249,387 shares of Emcure Pharmaceuticals Ltd. took place on the National Stock Exchange (NSE) at a price of Rs. 1375.00 per share. The total value of the trade amounted to Rs. 34.29 Crores.
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
66124
2.65%
1.99%
2.06%
May 2025
UTI Healthcare Fund Direct-Growth
70000
0.88%
-0.18%
-0.31%
May 2025
Axis Flexi Cap Fund Direct-Growth
0
0.00%
-0.03%
-0.03%
May 2025
ITI Pharma and Healthcare Fund Direct - Growth
0
0.00%
-1.09%
-1.17%
May 2025
Axis Equity Savings Fund Direct-Growth
6000
0.08%
-0.16%
-0.17%
May 2025
Aditya Birla Sun Life Equity Advantage Fund Direct -Growth
275555
0.64%
0.15%
0.12%
May 2025
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
23496
0.14%
0.02%
0.02%
May 2025
SBI Nifty Smallcap 250 Index Fund Direct - Growth
14734
0.14%
0.02%
0.02%
May 2025
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
7464
0.24%
0.04%
0.02%
May 2025
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
9519
0.14%
0.02%
0.01%
May 2025
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
4902
0.14%
0.02%
0.02%
May 2025
Motilal Oswal Nifty 500 Index Fund Direct - Growth
2457
0.01%
0.00%
0.00%
May 2025
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
1408
0.14%
0.02%
0.02%
May 2025
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
5155
0.14%
0.02%
0.01%
May 2025
Groww Nifty Smallcap 250 Index Fund Direct - Growth
1157
0.14%
0.02%
0.01%
May 2025
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
258
0.14%
0.02%
0.02%
May 2025
Axis Nifty 500 Index Fund Direct-Growth
285
0.01%
0.00%
0.00%
May 2025
Groww Nifty Total Market Index Fund Direct - Growth
304
0.01%
0.00%
0.00%
May 2025
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
75
0.04%
0.01%
0.01%
May 2025
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
1228
0.04%
0.01%
0.01%
May 2025
SBI Nifty 500 Index Fund Direct-Growth
898
0.01%
0.00%
0.00%
May 2025
ICICI Prudential Nifty 500 Index Fund Direct-Growth
26
0.01%
0.00%
0.00%
May 2025
Angel One Nifty Total Market Index Fund Direct - Growth
38
0.01%
0.00%
0.00%
May 2025
Mirae Asset Nifty Total Market Index Fund Direct-Growth
41
0.01%
0.00%
0.00%
May 2025
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1981. It develops, manufactures, and globally markets pharmaceutical products across various therapeutic areas. The company operates 13 manufacturing facilities in India and has a presence in over 70 countries, with a strong focus on India, Europe, and Canada. Emcure specializes in orals, injectables, and biotherapeutics, covering areas such as gynecology, cardiovascular, vitamins, minerals, nutrients, HIV antivirals, blood-related, and oncology treatments. The company has a portfolio of differentiated products, including chiral molecules, complex APIs, biologics, and novel drug delivery systems. Emcure has commercialized six in-house manufactured biologics and holds patents for specific treatments. The company expanded through mergers, acquisitions, and establishment of new facilities over the years. In July 2024, Emcure launched an Initial Public Offer.